BBP
BBP
About Virtus Biotech ETF
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name...
About Virtus Biotech ETF
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 CRNX | Crinetics Pharmaceuticals, Inc. | 3.20% | 37.49K | $3.14M |
 AGIO | Agios Pharmaceuticals, Inc. | 1.82% | 43.87K | $1.78M |
 RARE | Ultragenyx Pharmaceutical Inc. | 1.80% | 53.08K | $1.76M |
 MRNA | Moderna, Inc. | 1.77% | 25.89K | $1.74M |
 VSTM | Verastem, Inc. | 1.73% | 315.22K | $1.69M |
 SNDX | Syndax Pharmaceuticals, Inc. | 1.66% | 70.82K | $1.62M |
 RIGL | Rigel Pharmaceuticals, Inc. | 1.66% | 39.34K | $1.62M |
 BBIO | BridgeBio Pharma, Inc. | 1.64% | 19.35K | $1.61M |
 GERN | Geron Corporation | 1.63% | 1.12M | $1.60M |
 SRPT | Sarepta Therapeutics, Inc. | 1.62% | 84.42K | $1.59M |
 DNLI | Denali Therapeutics Inc. | 1.61% | 59.67K | $1.58M |
 ASND | Ascendis Pharma A/S | 1.61% | 5.93K | $1.57M |
 RYTM | Rhythm Pharmaceuticals, Inc. | 1.61% | 14.62K | $1.57M |
 LGND | Ligand Pharmaceuticals Incorporated | 1.60% | 5.06K | $1.56M |
 ACAD | ACADIA Pharmaceuticals Inc. | 1.60% | 61.28K | $1.56M |
 KURA | Kura Oncology, Inc. | 1.59% | 142.81K | $1.56M |
 XERS | Xeris Biopharma Holdings, Inc. | 1.59% | 190.34K | $1.55M |
 MIRM | Mirum Pharmaceuticals, Inc. | 1.58% | 13.01K | $1.55M |
 PTGX | Protagonist Therapeutics, Inc. | 1.56% | 11.77K | $1.53M |
 KNSA | Kiniksa Pharmaceuticals International, plc | 1.55% | 24.91K | $1.52M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Switzerland
Denmark
China
Germany
CanadaSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Switzerland Denmark China Germany CanadaHoldings (Top 20)
CRNX
Crinetics Pharmaceuticals, Inc.
AGIO
Agios Pharmaceuticals, Inc.
RARE
Ultragenyx Pharmaceutical Inc.
MRNA
Moderna, Inc.
VSTM
Verastem, Inc.
SNDX
Syndax Pharmaceuticals, Inc.
RIGL
Rigel Pharmaceuticals, Inc.
BBIO
BridgeBio Pharma, Inc.
GERN
Geron Corporation
SRPT
Sarepta Therapeutics, Inc.
DNLI
Denali Therapeutics Inc.
ASND
Ascendis Pharma A/S
RYTM
Rhythm Pharmaceuticals, Inc.
LGND
Ligand Pharmaceuticals Incorporated
ACAD
ACADIA Pharmaceuticals Inc.
KURA
Kura Oncology, Inc.
XERS
Xeris Biopharma Holdings, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
PTGX
Protagonist Therapeutics, Inc.
KNSA
Kiniksa Pharmaceuticals International, plc